Vanderbilt Institute Of Chemical Biology

The School of Medicine Basic Sciences and the Office of the Vice Provost for Research and Innovation launch the Innovation Ignition Fund. This pilot program offers up to $500,000 in funding and drug development mentorship from Vanderbilt scientists with expertise in translational research. Read More

The 2023 annual Vanderbilt Institute of Chemical Biology Symposium, featuring prominent scientists—including keynote speaker Dr. John Yates III—will be Aug. 8 at the Student Life Center. Sponsored by Ancora Innovation, the event will include discussions on innovative life science research and drug development, promising a day of knowledge sharing and networking for Vanderbilt students, staff and faculty. Read More

The Vanderbilt Institute of Chemical Biology presents Dr. Lynmarie Thompson of the University of Massachusetts on Wednesday, Jan. 12. Thompson will discuss “NMR and Hydrogen Exchange of Chemoreceptor Complexes Suggest Signaling Occurs via Stabilization of a Disordered Domain.” Read More

David Cortez, Richard N. Armstrong Chair for Innovation in Biochemistry and professor of biochemistry, has been named interim chair in the Department of Biochemistry beginning Jan. 1. This follows the departure of John York, who was recently named chief science officer of California-based food technology startup Impossible Foods. Read More

A bifunctional natural compound has been discovered with the potential to make antibiotic resistance to deadly infections less likely. Read More

The 16th annual Vanderbilt Institute of Chemical Biology Symposium is scheduled for Thursday, Aug. 6, from 8:30 a.m. to 5:15 p.m. CST. The event is sponsored by Ancora Innovation through Vanderbilt’s partnership with Deerfield Management and will be broadcast remotely. Read More

Sean Davies and colleagues are exploring lipid aldehydes produced during oxidative stress and their contribution to HDL dysfunction and atherosclerosis. Read More

This year’s Vanderbilt Institute of Chemical Biology Annual Symposium will be held on Thursday, Aug. 8, in the Vanderbilt Student Life Center. Read More

The event aims to expose faculty and staff to therapeutic antibody discovery in an academic setting and foster interest in submission of innovative ideas for antibody targets through an upcoming RFP for Ancora, the collaboration between Vanderbilt and Deerfield. Read More

The Vanderbilt Institute of Chemical Biology (VICB) will hold a Founders’ Celebration mini-symposium on March 28 to acknowledge the contributions of its founders, Lawrence Marnett, PhD, and Ned Porter, PhD, and to celebrate 15-plus years of success as a trans-institutional scientific incubator. Read More

Vanderbilt researchers have discovered that curcumin — the active ingredient in the spice turmeric — needs to be metabolically activated to exert anti-inflammatory effects. Read More

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology at Vanderbilt University School of Medicine, died from cancer Tuesday, July 25, at his home. He was 56. Read More

Vanderbilt investigators have developed a new method for measuring oxidative stress in human tumors, which provides insight into cancer development. Read More

H. Alex Brown, Ph.D., the Bixler-Johnson-Mayes Professor in the Department of Pharmacology, has been named interim director of the Vanderbilt Institute of Chemical Biology (VICB). Read More

Vanderbilt researchers have discovered a novel model of evolution for factors that control gene expression. Read More

New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections. Read More

Philip Low, Ph.D., director of the Purdue Center for Drug Discovery, will deliver the next Flexner Discovery Lecture on April 14. Read More

“Stay with science,” Nobel laureate Peter Agre, M.D., advised dozens of medical and graduate students who attended his lecture at Vanderbilt University Medical Center last week. “It will take you to fascinating places.” Read More

Peter Agre, M.D., a Nobel laureate who advocates the use of medical science to advance international diplomacy, will deliver the next Flexner Discovery Lecture at 4 p.m. Thursday, Jan. 21, in room 208 Light Hall. Read More

New findings add to the understanding of how the enzyme COX-2 works, which is critical to the development of COX-2-targeted anti-inflammatory drugs. Read More